High expression of the anti-ferroptotic enzyme GPX4 has been linked to poor survival outcomes [18], while the SLC7A11 transporter may be crucial in the development of platinum resistance in gastric cancer [19]. The gene discussed is GPX4; the disease is gastric cancer.